AroCell AB (publ) De
AroCell AB (publ) Delårsrapport 1 januari – 31 mars 2019
May 16, 2019 02:00 ET | AroCell AB
VD-ORD ”Biomarkörer kommer spela en allt större roll i hur vi identifierar och följer upp behandlingar av patienter med cancer de kommande åren.  Utvecklingen kring ökad individanpassning drivs av...
AroCell AB (publ) In
AroCell AB (publ) Interim Report 1st January to 31st March 2019
May 16, 2019 02:00 ET | AroCell AB
Word from the CEO “Biomarkers will play an increasingly important role in how we identify and follow up treatments for patients with cancer in the coming years. The development of an increased...
Ett nytt studieresul
Ett nytt studieresultat med AroCell TK 210 ELISA vid prostatacancer har accepterats för publicering
February 25, 2019 02:30 ET | AroCell AB
Studien med titeln “The combination of AroCell TK 210 ELISA with Prostate Health Index (PHI) or PSA density can improve the ability to differentiate prostate cancer from non-cancerous conditions”,...
New study results wi
New study results with AroCell TK 210 ELISA in prostate cancer has been accepted for publication
February 25, 2019 02:30 ET | AroCell AB
The study with the title “The combination of AroCell TK 210 ELISA with Prostate Health Index (PHI) or PSA density can improve the ability to differentiate prostate cancer from non-cancerous...
AroCell AB (publ) Bo
AroCell AB (publ) Bokslutskommuniké 2018
February 21, 2019 02:30 ET | AroCell AB
VD-ORD ”2018 har varit ett spännande år för AroCell med flera stora händelser. I april tecknade AroCell ett globalt icke exklusivt licensavtal med F. Hoffmann-La Roche Ltd (Roche). Roche är...
AroCell AB (publ) Ye
AroCell AB (publ) Year-End Report 2018
February 21, 2019 02:30 ET | AroCell AB
Word from the CEO ”2018 has been an exciting year for AroCell with several major events. In April, AroCell signed a global non-exclusive license agreement with F. Hoffmann-La Roche Ltd (Roche). Roche...
AroCell tecknar dist
AroCell tecknar distributörsavtal med Gongyingshi i Kina för AroCell TK 210 ELISA
January 15, 2019 02:00 ET | AroCell AB
Arocell tillkännager idag att ett distributionsavtal har tecknats med det Peking etablerade företaget Gongyingshi, för marknadsföring och distribution av AroCell TK 210™ ELISA i Kina. Läkemedels- och...
AroCell signs distri
AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA
January 15, 2019 02:00 ET | AroCell AB
AroCell AB (publ) announced today that a distribution agreement has been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210™ ELISA in China. ...
AroCell tecknar dist
AroCell tecknar distributörsavtal med Eurobio Scientific i Frankrike
December 20, 2018 02:00 ET | AroCell AB
Arocell tillkännager idag att ett distributionsavtal har tecknats med det franska företaget Eurobio Scientific, för distribution av AroCell TK 210 ELISA i Frankrike och Schweiz. AroCell TK 210 ELISA...
AroCell signs distri
AroCell signs distribution agreement with Eurobio Scientific in France
December 20, 2018 02:00 ET | AroCell AB
AroCell AB (publ) announced today that a distribution agreement has been signed with the French company Eurobio Scientific, for distribution of AroCell TK 210 ELISA in France and Switzerland. AroCell...